SMAD4 and myeloid sarcoma: C1ORF228, LPP, SSTR2, SLC8A1, DKK3 and SMAD4 have been associated with MS autoimmune response events, i.e. SSTR2 is a receptor for the neuro-protective molecule ‘somatostatin’ which presents a gradual reduction in response to inflammation.